Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Precision Antibacterial Company Raises $35M in New Funds

E. coli bacteria

A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds

Trial Set for Gut Infection Biologic Treatment

C. difficile in petri dish

A developer of biologic therapies for gastrointestinal disorders says FDA cleared its request for a clinical trial testing its treatment for C. difficile. . . . → Read More: Trial Set for Gut Infection Biologic Treatment

New Industry, Academic Studies Arrive at Space Station

International Space Station

Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions. . . . → Read More: New Industry, Academic Studies Arrive at Space Station

Electric Future of the Global Supply Chain

Several global issues contribute to the current international trade and manufacturing situation. . . . → Read More: Electric Future of the Global Supply Chain

India Authorizes Covid-19 Vaccines Designed in US

The government of India granted emergency clearance to two vaccines to prevent Covid-19 disease, both designed in U.S. research labs. . . . → Read More: India Authorizes Covid-19 Vaccines Designed in US

Plant-Based Protein Biotech Raises $3M in Seed Funds

Vertical farm in Finland

A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round. . . . → Read More: Plant-Based Protein Biotech Raises $3M in Seed Funds

Samsung, Biotech Partner on mRNA Vaccine Production

Vaccine vials

A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production

Cell Therapy Start-Up Raises $6M in Seed Funds

Stem cells

A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding. . . . → Read More: Cell Therapy Start-Up Raises $6M in Seed Funds

Joint Venture to Develop Stable RNA Covid-19 Vaccine

Shark

A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine

Biotechs Partner on Synthetic Plant-Based Drugs

Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs